FL-AMGTA
17.11.2020 14:01:06 CET | Business Wire | Press release
The Additive Manufacturer Green Trade Association (AMGTA), a global trade group created to foster and promote the environmental benefits of additive manufacturing (AM), announced today the publication of its first commissioned university research project, a literature-based systematic review of the environmental benefits of metal AM. The paper, titled, “State of Knowledge on the Environmental Impacts of Metal Additive Manufacturing” was written by Dr. Jeremy Faludi from Delft University of Technology and Corrie Van Sice from Dartmouth College.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201117005440/en/
Key takeaways from the report include that, while “AM generally has much higher carbon footprints per kg of material processed than CM [conventional manufacturing] when considering the direct manufacturing process itself”, but “impacts depend greatly on part geometry—a solid cube will be much lower impact to produce by machining, while a hollow shell or lattice can be lower impact to produce by AM.” The report further recognizes the need for additional life cycle assessment (LCA) studies to quantify environmental impacts: “More LCA studies are necessary to definitively compare metal AM to CM; especially direct comparisons of AM to machining, and especially for technologies such as binder jetting and DED. These LCAs should ideally also include more of the product life cycle.”
“We were pleased to work with Dr. Faludi and Ms. Van Sice on this study,” said Sherry Handel, the Executive Director of the AMGTA. “No one should expect metal AM to be a more sustainable way to manufacture basic metal parts given the focused energy inherent in laser melting, but AM should present a more sustainable course for manufacturing finished precision components.” Ms. Handel continued, “These findings validate the AMGTA’s plans to provide the industry with rigorous, independent, and ongoing research. The AMGTA will continue to commission studies and publish research findings in an effort to update the industry and other key stakeholders on what our eco-footprint is now and what we will need to focus on in the future to be more sustainable.”
About the Researchers
Jeremy Faludi, Ph.D., a leading sustainable engineering researcher, was selected by the AMGTA to oversee this project. Dr. Faludi is assistant professor of design engineering at Delft University of Technology, where he specializes in sustainable design methods and green 3D printing, and adjunct faculty of engineering at the Thayer School of Engineering at Dartmouth College. Dr. Faludi earned a Ph.D. in Mechanical Engineering at University of California Berkeley, a Master of Engineering in Product Design at Stanford University, and a B.A. in Physics from Reed College.
Corrie Van Sice was a senior research engineer at the Faludi Lab at the Thayer School of Engineering, Dartmouth College. Ms. Van Sice managed the Green 3D Printing Lab and assessed AM techniques to define best practices for sustainability in the industry. Before joining the Faludi Lab, she was the lead Materials and Processes R&D Engineer at MakerBot Industries in Brooklyn, NY where she developed and scaled print material manufacturing. Ms. Van Sice earned a Master of Professional Studies from the Interactive Telecommunications Program at New York University in 2011.
About AMGTA
The AMGTA was launched in November 2019 to promote the environmental benefits of additive manufacturing (AM) over traditional methods of manufacturing. The AMGTA is a non-commercial, unaffiliated organization open to any additive manufacturer or industry stakeholder that meets certain criteria relating to sustainability of production or process.
Founding Members of the AMGTA include Sintavia, LLC , a leading additive manufacturer focused on the aerospace, defense, and space industry; Taiyo Nippon Sanso Corporation (one of the operating companies under Nippon Sanso Holdings Corporation), a supplier of stable industrial gases to a wide variety of global industries; and QC Laboratories, Inc. , an industrial and commercial non-destructive testing laboratory focused on AM components.
Participating Members of the AMGTA include AMEXCI AB , Danish AM Hub , EOS , GE Additive , Materialise , National Manufacturing Institute Scotland , Siemens Digital Industries Software , SLM Solutions Inc. , and Stryker .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201117005440/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Omnes Partners With Apex Group to Tokenise Institutional Bitcoin Mining Structured Note on Base24.3.2026 09:00:00 CET | Press release
Omnes today announced a strategic partnership with Apex Group, a leading global financial services provider with over $3.5 trillion in assets serviced, to tokenise its flagship Omnes Mining Note "OMN". The OMN is an institutional grade structured note backed by Bitcoin hashrate, to be issued and managed on the Base Chain, the Ethereum L2 incubating at Coinbase, leveraging Apex Digital 3.0 for comprehensive tokenisation, administration, and transfer agency services as a fully integrated end to end solution. The OMN provides professional non-US investors with direct economic exposure to new Bitcoin production measured in hashrate, which is the computational power used to validate transactions and produce Bitcoin, without the operational complexities of managing mining infrastructure, hardware, energy, or regulatory hurdles. Issued as a secured debt note in Luxembourg, the tokenised OMN combines traditional financial structuring with blockchain enabled features, including on chain transfe
Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved24.3.2026 07:00:00 CET | Press release
Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory submission supporting a pivotal study in patients suffering from peritumoral brain edema (PTBE). In November 2025, Curatis raised CHF 1.2m to progress corticorelin. The cash position as of year end 2025 was comfortable, standing at CHF 1.9m. Recently, Curatis announced a license agreement for corticorelin for Japan with significant milestone payments. Business development and finances In 2025, product sales amounted to CHF 10.3m, while service revenue amounted to CHF 0.5m. On a full year basis, Curatis AG increased revenues in its distri
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 07:00:00 CET | Press release
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio® (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatric patients, and share four posters on AKLIEF® (trifarotene)1-8 Additional presentations related to Dermatological Skincare will explore how artificial intelligence can identify high-risk factors for sensitive skin and Cetaphil® in different skin types9 Data from Galderma’s Injectable Aesthetics portfolio will also show how its hyaluronic acid injectables, Restylane®, and neuromodulator, RelabotulinumtoxinA*, may address aesthetic needs across the face and décolletage10-14 A total of 22 presentations will reinforce the value of Galderma’s broad and comprehensive portfolio in meeting varied patient needs across Therapeutic Dermatology, Injectable Aesthetics and Dermatological Skincare Galderma (SIX: GALD), the pure-play dermatology category leader, wi
Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager24.3.2026 07:00:00 CET | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323639110/en/ Constance Sabbagh, General Manager, France “France is essential to Avanzanite’s European vision,” said Adam Plich, Co-founder and CEO of Avanzanite. “With its leadership in rare disease policy through its National Rare Disease Plans, care networks and scientific innovation, France is one of the most significant healthcare
HJS Foundation Releases JEP Protocol & HJS Framework: The "Black Box" for AI, Enabling Verifiable Human Oversight24.3.2026 04:36:00 CET | Press release
HJS Foundation (Human Judgment Systems Foundation) today released two complementary solutions: the Judgment Event Protocol (JEP) and the Human Judgment Structure (HJS) framework. As a minimalist open standard, JEP generates tamper-proof records of AI decision accountability, just like an aircraft black box; HJS embeds human judgment logic into AI operation processes — together, they transform "human oversight" from a regulatory requirement into a verifiable technical fact, providing an optional technical solution for AI accountability. How to prove that AI decisions (such as loan approvals, medical diagnoses, border screenings, etc.) have undergone human review? JEP generates immutable audit trails of human intervention through four cryptographic primitives — Judge, Verify, Delegate, Terminate; HJS builds a controllable and accountable system to prevent risks such as AI drift and ensure that human judgment guides AI operations. Current systems rely on alterable post-hoc documentation,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
